Control of electronic transport in graphene by electromagnetic dressing

We demonstrated theoretically that the renormalization of the electron energy spectrum near the Dirac point of graphene by a strong high-frequency electromagnetic field (dressing field) drastically depends on polarization of the field. Namely, linear polarization results in an anisotropic gapless energy spectrum, whereas circular polarization leads to an isotropic gapped one. As a consequence, the stationary (dc) electronic transport in graphene strongly depends on parameters of the dressing field: A circularly polarized field monotonically decreases the isotropic conductivity of graphene, whereas a linearly polarized one results in both giant anisotropy of conductivity (which can reach thousands of percents) and the oscillating behavior of the conductivity as a function of the field intensity. Since the predicted phenomena can be observed in a graphene layer irradiated by a monochromatic electromagnetic wave, the elaborated theory opens a substantially new way to control electronic properties of graphene with light.Comment: Published versio

Quantum phase transition triggering magnetic BICs in graphene

Graphene hosting a pair of collinear adatoms in the phantom atom configuration has pseudogap with cubic scaling on energy, $\Delta\propto|\varepsilon|^{3}$ which leads to the appearance of spin-degenerate bound states in the continuum (BICs) [Phys. Rev. B 92, 045409 (2015)]. In the case when adatoms are locally coupled to a single carbon atom the pseudogap scales linearly with energy, which prevents the formation of BICs. In this Letter, we explore the effects of non-local coupling characterized by the Fano factor of interference $q_{0},$ tunable by changing the slope of the Dirac cones in the graphene band-structure. We demonstrate that three distinct regimes can be identified: i) for $q_{0}<q_{c1}$ (critical point) a mixed pseudogap $\Delta\propto|\varepsilon|,|\varepsilon|^{2}$ appears yielding a phase with spin-degenerate BICs; ii) near $q_{0}=q_{c1}$ when $\Delta\propto|\varepsilon|^{2}$ the system undergoes a quantum phase transition in which the new phase is characterized by magnetic BICs and iii) at a second critical value $q_{0}>q_{c2}$ the cubic scaling of the pseudogap with energy $\Delta\propto|\varepsilon|^{3}$ characteristic to the phantom atom configuration is restored and the phase with non-magnetic BICs is recovered. The phase with magnetic BICs can be described in terms of an effective intrinsic exchange field of ferromagnetic nature between the adatoms mediated by graphene monolayer. We thus propose a new type of quantum phase transition resulting from the competition between the states characterized by spin-degenerate and magnetic BICs

Catching the Bound States in the Continuum of a Phantom Atom in Graphene

We explore theoretically the formation of bound states in the continuum (BICs) in graphene hosting two collinear adatoms situated at different sides of the sheet and at the center of the hexagonal cell, where a phantom atom of a fictitious lattice emulates the six carbons of the cell. We verify that in this configuration the local density of states (LDOS) near the Dirac points exhibits two characteristic features: i) the cubic dependence on energy instead of the linear one for graphene as found in New J. Phys. 16, 013045 (2014) and ii) formation of BICs as aftermath of a Fano destructive interference assisted by the Coulomb correlations in the adatoms. For the geometry where adatoms are collinear to carbon atoms, we report absence of BICs

Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia

To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAnalysis of 2668 children with acute lymphoblastic leukemia (ALL) treated in two successive Nordic clinical trials (Nordic Society of Paediatric Haematology and Oncology (NOPHO) ALL-92 and ALL-2000) showed that 75% of all patients are cured by first-line therapy, and 83% are long-term survivors. Improvements in systemic and intrathecal chemotherapy have reduced the use of central nervous system (CNS) irradiation to <10% of the patients and provided a 5-year risk of isolated CNS relapse of 2.6%. Improved risk stratification and chemotherapy have eliminated the previous independent prognostic significance of gender, CNS leukemia and translocation t(1;19)(q23;p13), whereas the post-induction level of minimal residual disease (MRD) has emerged as a new risk grouping feature. Infant leukemia, high leukocyte count, T-lineage immunophenotype, translocation t(4;11)(q21;q23) and hypodiploidy persist to be associated with lower cure rates. To reduce the overall toxicity of the treatment, including the risk of therapy-related second malignant neoplasms, the current NOPHO ALL-2008 protocol does not include CNS irradiation in first remission, the dose of 6-mercaptopurine is reduced for patients with low thiopurine methyltransferase activity, and the protocol restricts the use of hematopoietic stem cell transplantation in first remission to patients without morphological remission after induction therapy or with high levels of MRD after 3 months of therapy

Klarsprogsarbejdet i Island

[Der findes ikke resumé til denne artikel.

Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.

To access publisher full text version of this article. Please click on the hyperlink in Additional Links field.Lymphoplasmacytic lymphoma (LPL)/Waldenström macroglobulinemia (WM) is a B-cell disorder resulting from the accumulation, predominantly in the bone marrow, of clonally related lymphoplasmacytic cells. LPL/WM is a very rare disease, with an incidence rate of 3-4 cases per million people per year.Currently, the causes of LPL/WM are poorly understood; however, there are emerging data to support a role for immune-related factors in the pathogenesis of LPL/WM. In addition, data show that genetic factors are of importance in the etiology of LPL/WM. In this paper, we will review the current knowledge about familiality of LPL/WM and provide novel data on solid tumors and myeloid malignancies in first-degree relatives of LPL/WM patients.Swedish Cancer Society Stockholm County Council Karolinska Institutet Foundations National Institutes of Health, National Cancer Institute Roch

The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study

To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked FilesIn the present study, we aimed to evaluate 2 hypotheses. First, we hypothesize that prior malignancy is a proxy for genetic susceptibility that could be a risk factor for subsequent malignancy development in multiple myeloma (MM) patients. Second, we hypothesize that survival after MM is influenced by a prior malignancy. All patients diagnosed with MM from 1 January 1973 to 31 December 2010 were identified from the Swedish Cancer Register. Cox regression model was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) where prior malignancy was compared in MM patients who developed a subsequent malignancy and MM patients who did not. In another Cox regression model, survival was compared in MM patients with and without a prior malignancy diagnosis. A total of 19 791 patients were diagnosed with MM. Patients with a prior malignancy diagnosis had a significantly increased risk of developing a subsequent malignancy compared with MM patients without (HR 1.42, 95% CI 1.23-1.65, P 1 prior malignancy reduces survival even further.Asrun Einarsdottir Foundation in Iceland Blodcancerfonden Swedish Cancer Society Stockholm County Council Karolinska Institutet Foundation University of Iceland Research Fund Icelandic Centre for Research Landspitali University Hospital Research Fund Marie Curie Career Integration Grant Memorial Sloan Kettering Cancer Center Core Grant by the National Cancer Institute, National Institutes of Healt

Akademískt frelsi, ábyrgð og hömlur : Sjónarmið háskólakennara á Íslandi

Akademískt frelsi er órjúfanlegur þáttur háskólastarfs. Í greininni er rakið inntak og mikilvægi akademísks frelsis og sagt frá niðurstöðum rannsókna á skilningi íslenskra háskólakennara á því og ógnum þess. Tilgreindir eru tveir inntaksþættir, (a) frjálst val viðfangsefna og aðferða í rannsóknum og kennslu og (b) þekkingar- og heilindakrafa. Greinin byggir á gögnum úr þremur gagnasöfnum sem safnað var í tveimur rannsóknarverkefnum, þ.e. gögnum úr spurningakönnun og viðtölum; hópviðtölum í fyrra rannsóknarverkefninu og einstaklingsviðtölum í því síðara. Spurningakönnunin var lögð fyrir árið 2011, hópviðtölin tekin árið 2014 og einstaklingsviðtölin árin 2019-2020. Alls var rætt við 48 akademíska starfsmenn úr þremur háskólum, 26 konur og 22 karla. Viðmælendur voru spurðir hvaða skilning þeir legðu í akademískt frelsi og hvernig það tengdist ólíkum þáttum starfs þeirra sem rannsakenda og háskólakennara. Niðurstöðurnar eru þær að íslenskir háskólakennarar meta akademískt frelsi mikils og tengja það helst við frjálst val viðfangsefna og aðferða í rannsóknum en einnig kennslu. Skilningur er á því að frelsinu fylgja kröfur um þekkingu og heilindi sem lúta jafningjamati, bæði í rannsóknum og kennslu. Viðmælendur finna fyrir því að á sumum sviðum er þrengt að akademísku frelsi þeirra, og kemur sá þrýstingur frá stjórnmálum og atvinnulífi, og sömuleiðis geta rannsóknasjóðir, matskerfi og þröngir útgáfukostir takmarkað frelsi rannsakenda. Hvorki komu fram áhyggjur af lausráðningu né þöggun. Svipuð viðhorf koma fram í öllum þremur gagnasöfnunum.Peer reviewe

Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based study.

Characteristics of patients with community-acquired pneumonia (CAP) due to pandemic influenza A 2009 (H1N1) have been inadequately compared to CAP caused by other respiratory pathogens. The performance of prediction rules for CAP during an epidemic with a new infectious agent are unknown. Prospective, population-based study from November 2008-November 2009, in centers representing 70% of hospital beds in Iceland. Patients admitted with CAP underwent evaluation and etiologic testing, including polymerase chain reaction (PCR) for influenza. Data on influenza-like illness in the community and overall hospital admissions were collected. Clinical and laboratory data, including pneumonia severity index (PSI) and CURB-65 of patients with CAP due to H1N1 were compared to those caused by other agents. Of 338 consecutive and eligible patients 313 (93%) were enrolled. During the pandemic peak, influenza A 2009 (H1N1) patients constituted 38% of admissions due to CAP. These patients were younger, more dyspnoeic and more frequently reported hemoptysis. They had significantly lower severity scores than other patients with CAP (1.23 vs. 1.61, P= .02 for CURB-65, 2.05 vs. 2.87 for PSI, P<.001) and were more likely to require intensive care admission (41% vs. 5%, P<.001) and receive mechanical ventilation (14% vs. 2%, P= .01). Bacterial co-infection was detected in 23% of influenza A 2009 (H1N1) patients with CAP. Clinical characteristics of CAP caused by influenza A 2009 (H1N1) differ markedly from CAP caused by other etiologic agents. Commonly used CAP prediction rules often failed to predict admissions to intensive care or need for assisted ventilation in CAP caused by the influenza A 2009 (H1N1) virus, underscoring the importance of clinical acumen under these circumstances.Icelandic Center for Research, Rannis 100436021 Landspitali University Hospital Science Fun